Skip to main content
Psychological DistressDigital healthBehavioralChildren's healthBehavioral

What this study is

The objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital suicide prevention intervention for cyberbullied adolescents.

The specific aims are to:

Aim #1: Conduct a randomized controlled trial (RCT) comparing Flourish+Questionnaires vs. Questionnaires Alone among cyberbullied youth at-risk for suicide ages 12-17 (N=80, >35% underserved youth).

H2a. Primary outcome: Feasibility will be evidenced by recruitment/retention rates > 80% and imHere4U engagement > 70%.

H2b. Secondary outcomes: Youth assigned to Flourish+Questionnaires will report improved problem-solving capacity, distress tolerance, and motivation and reduced distress and suicidal ideation than youth assigned to Questionnaires Alone over the 6-month follow-up period.

Exploratory Aim: Examine the feasibility of delivering feedback on online interactions from machine learning algorithms. All youth assigned to Flourish may optionally provide their social media data to receive feedback from machine learning algorithms. H3a. Feedback from algorithms will have high acceptability (identified via qualitative themes and >70% acceptance rates) and usability, defined by mean scores on Post-Study System and Usability Questionnaire (PSSUQ) > 6.

What's being tested

  • Flourish

    Intervention · BEHAVIORAL

    Flourish is a text messaging program that aims to improve coping following cyberbullying and reduce suicide risk among youth.

  • Questionnaires of Online Experiences

    Intervention · BEHAVIORAL

    Adolescents will receive brief questionnaires related to their online experiences and the impact those experiences have had on their stress level.

Study details

Sponsor
University of Pittsburgh
Conditions
Psychological Distress · Suicidal Ideation
Enrolling
80 people
Starts
2023-11-21
Est. completion
2027-08
Design
Single-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗